...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone


BREAKING: Empower Clinics Announces Joint Venture with Heritage Cannabis for the Production of Hemp Derived CBD Oils and Formulated Products in Oregon USA

  • Heritage, via its wholly owned subsidiary Purefarma Solutions Inc., will install extraction units and related downstream extraction equipment inside Empower’s existing 5,000 sq. ft. licenced hemp processing facility in Sandy, OR.
  • JV will be equally funded by both companies with Heritage investing an initial $500,000 for start-up funds, as the build out completes and the JV secures high quality hemp supply from local growers
  • Once operational, the JV will begin producing proprietary branded products for Empower’s corporately owned physician staffed health clinics in Washington State, Oregon, Nevada and Arizona

Epw logo1

Hub On AGORACOM / Read Release

Message: BETonMACE Enrollment

and patient discontinuation rate which we didn't hear anything about until the last year. In my estimation the funding issue added about 6 months to the projected time to 250 events.

Tada, i don't remember reading about the discontinuing rate, ... can you remind me what we heard,..?

So the 6 months late (trial ended april 2019 instead of nov 2018) was because of funding and not because treated group was doing well...?


New Message
Please login to post a reply